CW May 2005
Volume 14Issue Number 5 May 2005 ISSN 10593802 New Targeted Therapy Improved Progression-Free Survival in Advanced Colorectal Cancer PatientsInitial results with the anti-angiogenesis drug PTK/ZK show improvement in progression-free survival in advanced colorectal cancer patients.
Go to Previous Page Go to Next Page Source & Additional Reading J. R. Hecht, Clinical Professor of Medicine, Director, Gastrointestinal Oncology Program, Jonsson Comprehensive Cancer Center, University of California at Los Angeles School of Medicine. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW May 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
